Gene · 3198
Papers1,717
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,717
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis. | Front Genet | 2022 | 36437956 | PubTator, text mining | PubMed |
| Ovarian cancer stem cells: Critical roles in anti-tumor immunity. | Front Genet | 2022 | 36437919 | PubTator, text mining | PubMed |
| Circulating Long Non-Coding RNAs Could Be the Potential Prognostic Biomarker for Liquid Biopsy for the Clinical Management of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36428681 | PubTator, text mining | PubMed |
| Modulation of HERV Expression by Four Different Encephalitic Arboviruses during Infection of Human Primary Astrocytes. | Viruses | 2022 | 36423114 | PubTator, text mining | PubMed |
| Reconstitution of human adrenocortical specification and steroidogenesis using induced pluripotent stem cells. | Dev Cell | 2022 | 36413950 | PubTator, text mining | PubMed |
| The biological function of m6A methyltransferase KIAA1429 and its role in human disease. | PeerJ | 2022 | 36389416 | PubTator, text mining | PubMed |
| Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance. | Front Oncol | 2022 | 36387262 | PubTator, text mining | PubMed |
| A Missense Mutation in LMX1A in a Patient With Moebius Syndrome: A Case Report. | Cureus | 2022 | 36381759 | PubTator, text mining | PubMed |
| Human multilineage pro-epicardium/foregut organoids support the development of an epicardium/myocardium organoid. | Nat Commun | 2022 | 36379937 | PubTator, text mining | PubMed |
| Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential. | Cancer Cell Int | 2022 | 36376832 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia. | Life (Basel) | 2022 | 36362925 | PubTator, text mining | PubMed |
| Retraction: Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1. | Biosci Rep | 2022 | 36354012 | PubTator, text mining | PubMed |
| Mesenchymal stromal cells in the thymus. | Inflamm Regen | 2022 | 36320070 | PubTator, text mining | PubMed |
| Tumor-promoting myeloid cells in the pathogenesis of human oncoviruses: potential targets for immunotherapy. | Cancer Cell Int | 2022 | 36303138 | PubTator, text mining | PubMed |
| Integrated analysis of bulk and single-cell RNA-seq reveals the role of MYC signaling in lung adenocarcinoma. | Front Genet | 2022 | 36299592 | PubTator, text mining | PubMed |
| Is IIIG9 a New Protein with Exclusive Ciliary Function? Analysis of Its Potential Role in Cancer and Other Pathologies. | Cells | 2022 | 36291193 | PubTator, text mining | PubMed |
| Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. | Biomedicines | 2022 | 36289829 | PubTator, text mining | PubMed |
The Oncogenic and Tumor Suppressive Long Non-Coding RNA-microRNA-Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer. | Biomedicines | 2022 | 36289596 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance. | Hepatoma Res | 2022 | 36277115 | PubTator, text mining | PubMed |
| Exploring biomarkers and transcriptional factors in type 2 diabetes by comprehensive bioinformatics analysis on RNA-Seq and scRNA-Seq data. | Ann Transl Med | 2022 | 36267740 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3198/papers?page=12